GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd: Rs. 600 Cr Preferential Issue Funds Used as Planned

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 04 Nov 2026, 09:00 PM IST  ·  BSE ID: 55f30e7a-8cb6-4aa7-897b-c99da60a0a77
View Original BSE Filing (PDF)
💡
In Simple Terms
The company confirmed that money raised from shareholders is being spent exactly as promised and planned.
🤖 AI Summary
  • Krishna Institute of Medical Sciences Ltd confirms NIL deviation for Rs. 600 Cr preferential issue funds.
  • Funds raised on August 19, 2026, were utilised as per the June 15, 2026, Postal Ballot Notice.
  • Audit Committee reviewed and noted the NIL deviation for the quarter ending September 30, 2026.
  • No variation found in the utilisation of Rs. 150 Cr received (25% of amount raised).
🔢 Key Numbers - exact figures from BSE filing, not rounded
Amount Raised
Rs. 600 Cr
Amount Received (25% of the amount Raised)
Rs. 150 Cr
Funds Utilised
Nil
🏢 How This Affects the Company
💰
Financial Impact
The company has confirmed adherence to the stated utilisation plan for funds raised via preferential allotment, providing financial transparency.
⚠️
Risk Impact
This confirmation of fund utilisation mitigates any immediate concerns regarding the deployment of capital from the preferential issue.
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders. This filing is for informational and compliance purposes.
👤
Who Is Affected
All shareholders are indirectly affected by the company's transparent and compliant fund management, ensuring alignment with stated objectives.
🔍
Management Signal
This filing signals management's commitment to adhering to the planned utilisation of funds and maintaining transparency with stakeholders.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Next quarterly results for FY27 for ongoing fund utilisation updates.
Management commentary on further utilisation of the remaining preferential issue funds.
Auditor's report for subsequent periods on fund deployment.
LOW RISK Filing confirms no deviation in fund utilisation, mitigating immediate capital deployment risks.
💡 Investor Takeaway
Krishna Institute of Medical Sciences Ltd confirms NIL deviation in the utilisation of Rs. 600 Cr preferential issue funds for Q2 FY27. The company is using Rs. 150 Cr (25% received) as planned.
⚖️ Strengths & Concerns

✅ Positives

  • Confirmation of NIL deviation in the utilisation of Rs. 600 Cr from preferential issue for Q2 FY27.
  • Audit Committee review and approval of the fund utilisation statement for the period ending September 30, 2026.
❓ Frequently Asked Questions
What is Krishna Institute of Medical Sciences Ltd's update on its Rs. 600 Cr preferential issue?
The company confirmed NIL deviation in the utilisation of Rs. 600 Cr funds raised through preferential issue for the quarter ended September 30, 2026.
How much of the Rs. 600 Cr preferential issue funds were used by KIMS in Q2 FY27?
For the quarter ended September 30, 2026, the funds utilised were Nil, with Rs. 150 Cr (25% of amount raised) received towards the preferential issue.
Was there any deviation in the utilisation of funds raised by Krishna Institute of Medical Sciences Ltd?
No, Krishna Institute of Medical Sciences Ltd confirmed NIL deviation or variation in the utilisation of funds from the objects stated in the Postal Ballot Notice dated June 15, 2026.
Which committee reviewed the deviation report for KIMS' preferential issue funds?
The Audit Committee of Krishna Institute of Medical Sciences Limited reviewed the statement of deviation or variation in its meeting held on November 4, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.